BioArctic AB (publ) Cash Flow-to-Debt Ratio
BioArctic AB (publ) cash flow-to-debt ratio. BioArctic AB (publ) (BIOA-B) has a Cash Flow-to-Debt Ratio of 0.17x as of June 2026, meaning its operating cash flow of Skr137.84 Million could theoretically repay 0% of its total liabilities (Skr802.78 Million) in one year. Check BIOA-B operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioArctic AB (publ) (2015–2025)
Cash flow-to-debt ratio of BioArctic AB (publ) from 2015 to 2025. Historical debt coverage capacity for BioArctic AB (publ) across 11 annual periods. Check how aggressively does BioArctic AB (publ) reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
BioArctic AB (publ) Cash Flow-to-Debt Ratio by Year (2015–2025)
BioArctic AB (publ) cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for BioArctic AB (publ). For the full cash flow conversion analysis, see how efficiently does BioArctic AB (publ) generate cash.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 2.35x | Skr1.43 Billion | Skr608.14 Million | ▲ +261.2% |
| 2024 | -1.46x | Skr-316.33 Million | Skr216.74 Million | ▼ -165.7% |
| 2023 | 2.22x | Skr309.69 Million | Skr139.50 Million | ▲ +605.7% |
| 2022 | -0.44x | Skr-31.64 Million | Skr72.06 Million | ▲ +65.9% |
| 2021 | -1.29x | Skr-140.46 Million | Skr109.05 Million | ▼ -99.5% |
| 2020 | -0.65x | Skr-92.34 Million | Skr143.01 Million | ▼ -141.2% |
| 2019 | 1.57x | Skr327.17 Million | Skr208.84 Million | ▲ +393.9% |
| 2018 | -0.53x | Skr-200.06 Million | Skr375.31 Million | ▼ -98.7% |
| 2017 | -0.27x | Skr-135.33 Million | Skr504.35 Million | ▼ -125.7% |
| 2016 | 1.04x | Skr675.13 Million | Skr647.22 Million | ▲ +244.9% |
| 2015 | -0.72x | Skr-16.43 Million | Skr22.83 Million | — |